Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$834M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$784M |
| 5 |
Norfolk Southern
NSC
|
+$613M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.19B |
| 2 |
Palantir
PLTR
|
+$742M |
| 3 |
HES
Hess
HES
|
+$478M |
| 4 |
Oracle
ORCL
|
+$465M |
| 5 |
Thomson Reuters
TRI
|
+$442M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.36% |
| 2 | Technology | 9.28% |
| 3 | Financials | 7.68% |
| 4 | Healthcare | 6.5% |
| 5 | Industrials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Cannae Holdings
CNNE
$678M
| $3.02M | ﹤0.01% |
164,707
+77,183
| +88% | +$1.53M |
|
3552
Savara
SVRA
$1.08B
| $3.01M | ﹤0.01% |
+844,177
| New | +$2.5M |
|
|
FAC
3553
Factorial Energy Inc
FAC
$525M
| $3.01M | ﹤0.01% |
300,001
+1
| +0% | +$10 |
|
3554
Red Rock Resorts
RRR
$3.37B
| $3.01M | ﹤0.01% |
49,289
-37,985
| -44% | -$2.23M |
|
3555
Jack in the Box
JACK
$311M
| $3.01M | ﹤0.01% |
152,138
+128,182
| +535% | +$2.55M |
|
3556
PUT
BrightSpring Health Services
BTSG
$11.7B
| $3.01M | ﹤0.01% |
+101,700
| New | +$2.36M |
|
3557
CALL
Bit Digital
BTBT
$516M
| $3M | ﹤0.01% |
+1,000,000
| New | +$3.03M |
|
3558
Protara Therapeutics
TARA
$226M
| $2.99M | ﹤0.01% |
688,256
+124,136
| +22% | +$402K |
|
3559
Suzano
SUZ
$11B
| $2.99M | ﹤0.01% |
317,983
-1,526,911
| -83% | -$14.5M |
|
|
LX
3560
LexinFintech Holdings
LX
$194M
| $2.99M | ﹤0.01% |
560,400
+380,362
| +211% | +$2.43M |
|
3561
Ultragenyx Pharmaceutical
RARE
$2.52B
| $2.98M | ﹤0.01% |
99,213
-387,128
| -80% | -$11.6M |
|
3562
Rigel Pharmaceuticals
RIGL
$868M
| $2.98M | ﹤0.01% |
105,301
+74,042
| +237% | +$2.21M |
|
3563
Covenant Logistics
CVLG
$888M
| $2.98M | ﹤0.01% |
137,486
+43,384
| +46% | +$1.04M |
|
3564
VanEck Pharmaceutical ETF
PPH
$993M
| $2.97M | ﹤0.01% |
+32,900
| New | +$2.88M |
|
3565
BWX Technologies
BWXT
$14B
| $2.97M | ﹤0.01% |
16,112
-12,376
| -43% | -$1.99M |
|
3566
Intrepid Potash
IPI
$506M
| $2.97M | ﹤0.01% |
97,068
+17,420
| +22% | +$548K |
|
3567
Stock Yards Bancorp
SYBT
$2.48B
| $2.97M | ﹤0.01% |
42,372
-32,731
| -44% | -$2.53M |
|
3568
CALL
XP
XP
$8.96B
| $2.97M | ﹤0.01% |
+157,800
| New | +$2.83M |
|
3569
BRC Inc
BRCC
$120M
| $2.96M | ﹤0.01% |
190,044
+79,246
| +72% | +$1.27M |
|
3570
Civeo
CVEO
$342M
| $2.96M | ﹤0.01% |
128,810
+88,267
| +218% | +$2.07M |
|
3571
Aclaris Therapeutics
ACRS
$885M
| $2.95M | ﹤0.01% |
1,554,458
-2,282,922
| -59% | -$3.98M |
|
|
WENNU
3572
Wen Acquisition Corp Unit
WENNU
| $2.95M | ﹤0.01% |
283,170
-399,267
| -59% | -$4.2M |
|
3573
PUT
Freshworks
FRSH
$3.62B
| $2.94M | ﹤0.01% |
+250,000
| New | +$3.37M |
|
3574
Viridian Therapeutics
VRDN
$2.61B
| $2.94M | ﹤0.01% |
136,280
+76,844
| +129% | +$1.39M |
|
3575
Main Street Capital
MAIN
$5.47B
| $2.94M | ﹤0.01% |
46,196
+31,727
| +219% | +$2.05M |
|
Similar funds
Israel Englander's Q3 2025 Portfolio in Review
As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
- Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
- Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
- Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
- Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
- Israel Englander opened 800 new positions and closed 633 in Q3 2025.
- Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.